Investigating how mTORC1 signaling affects type 1 diabetes
Role of mTORC1 signaling in type 1 diabetes
This study is looking at how a specific signaling pathway in the body might help protect insulin-producing cells in people with type 1 diabetes from damage caused by inflammation, with the hope of finding new ways to keep these important cells healthy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Miami School of Medicine NIH-funded |
| Lab location | 1 site (Coral Gables, United States) |
| Project ID | NIH-11046570 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of mTORC1 signaling in type 1 diabetes (T1D), a condition characterized by the destruction of insulin-producing beta cells. The study explores how mTORC1 regulates beta cell mass and proliferation through its effects on specific proteins, particularly 4E-BPs. By using genetically modified mice, the researchers aim to determine if inhibiting the interaction between 4E-BP2 and eIF4E can protect beta cells from damage caused by inflammation, which is a significant factor in T1D progression. The findings could lead to new therapeutic strategies aimed at preserving beta cell function in patients with T1D.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with type 1 diabetes, particularly those experiencing challenges with beta cell function.
Not a fit: Patients with type 2 diabetes or other forms of diabetes unrelated to autoimmune processes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that help preserve insulin-producing beta cells in patients with type 1 diabetes.
How similar studies have performed: Preliminary studies have shown promising results with similar approaches, indicating that targeting the mTORC1 pathway may be a viable strategy for managing type 1 diabetes.
Where this research is happening
Coral Gables, United States
- University of Miami School of Medicine — Coral Gables, United States (Active)
Researchers
- Principal investigator: Bernal-Mizrachi, Ernesto — University of Miami School of Medicine
- Study coordinator: Bernal-Mizrachi, Ernesto
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.